DXS International Plc is a United Kingdom-based healthcare technology company that designs, develops, and distributes clinical decision support systems and digital workflow management software for primary care medical providers. Founded in 1999 and headquartered in Farnham, Surrey, the company operates primarily across the United Kingdom, serving National Health Service general practitioner practices, Integrated Care Boards, Primary Care Networks, and healthcare commissioning bodies through its operating subsidiary, DXS UK Limited. The company’s core product and service portfolio includes DXS Point-of-Care, an electronic clinical decision support platform integrated directly into electronic health record systems such as EMIS Web and TPP SystmOne to provide clinicians with real-time access to localized clinical guidelines, diagnostic pathways, referral forms, and patient information leaflets during consultations; ExpertCare, an automated clinical management and medicine optimization solution designed to assist practitioners in managing chronic conditions such as hypertension and chronic kidney disease through evidence-based treatment recommendations and medication titration protocols; CompleteCare, a clinical review and assessment platform that standardizes chronic disease management workflows and assists medical practices in achieving Quality and Outcomes Framework and Enhanced Services targets; and digital referral management solutions that optimize patient triage, reduce administrative overhead, and facilitate communication between primary and secondary care providers. In recent operational and strategic developments, DXS International has focused on expanding the commercial rollout of its ExpertCare platform across regional Integrated Care Boards to support preventative healthcare and hypertension management programs. The company has also advanced the migration of its core clinical decision support infrastructure to modern cloud-delivered software-as-a-service architectures, deepened technical interoperability with next-generation primary care clinical systems, and aligned its commercial offering with NHS structural reforms to address elective care referral backlogs and enhance regional population health management.